SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS
· Real-Time Price · USD
2.28
0.02 (0.88%)
At close: Sep 05, 2025, 3:59 PM
2.27
-0.44%
After-hours: Sep 05, 2025, 04:10 PM EDT
SAB Biotherapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for SABS stock have an median target of 11.5, with a low estimate of 9 and a high estimate of 12. The median target predicts an increase of 404.39% from the current stock price of 2.28.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 9 | 11 | 11.5 | 12 |
| Change | 294.74% | 382.46% | 404.39% | 426.32% |
Latest Analyst Insight Report
Chardan Capital has reiterated a Buy rating for SA... Unlock content with Pro Subscription
Updated Aug 08, 2025
| Rating | Nov 24 | Jan 25 | Apr 25 | May 25 | Jul 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 2 | 2 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 1 | 1 |
Financial Forecast this Year
Revenue This Year
200K
from 1.32M
Increased by -84.9%
Revenue Next Year
400K
from 200K
Increased by 100.0%
EPS This Year
-2.21
from -3.68
Increased by 39.9%
EPS Next Year
-1.17
from -2.21
Increased by 47.1%